It is expected that cotreatment of colorectal cancer cells with histone deacetylase inhibitors and indole-3-carbinol 70, would suppress histone deacetylase inhibitor-mediated apoptosis, as would rapamycin, given the importance of mTOR activity 71,72. This evidence concerns the gene MTOR and colorectal cancer.